AACR 2017: Triple-negative breast cancer patients who responded to immunotherapy had long-term survival benefit
Among patients with metastatic triple-negative breast cancer (TNBC) who were treated with the anti-PD-L1 cancer…
Browsing: immunotherapy to treat Triple-negative breast cancer